Abstract

  The aim of the study was to synthesize (La, Sr)MnO3 no particles as heating mediator and evaluate the ability of nano hyperthermia to affect ascitic forms of cancer as well tumor cells resistant to cytostatic. Nanoparticles have been synthesized by sol-gel method and magnetic fluid on the basis of nanoparticles was prepared. It is heated under alternating magnetic field (300kHz,7.7kA/m) and able to heat tumor cells. Nano hyperthermia is able to enhance the sensitivity of cisplatin resistant tumour cells (MCF-7Cp) to cytostatic action: about 30% of resistant tumor cells could overcome the resistance to cisplatin. Anti-tumor effect of nano hyperthermia was confirmed by the absence of ascitic fluid in peritoneal cavity of mice with lymphocytic leukaemia Р-388 (аscitic form). It may be explained by the ability of nanoparticles to penetrate into the tumor cells and to cause the phenomenon so named as “intracellular hyperthermia” as it was demonstrated by electron microscopy. Applying of nano hyperthermia using (La,Sr)MnO3 nanoparticles may be considered as the promising way to help in approaches to the problem of tumor cell resistance as alternative to the conventional chemotherapies. Nano hyperthermia intraperitoneal chemotherapy may be helpful within various multimodality strategies for prevention and treatment peritoneal carcinomatosis or malignant ascites.

Keywords:nanoparticles; magnetic fluid; nano hyperthermia; drug resistance, ascitic fluid, electron microscopy

References

1. Van der Zee J., et al. “The Kadota Fund International Forum 2004 - clinical group consensus”. International Journal of Hyperthermia 24 (2008): 111-122.
2. Issels RD., et al. “Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study”. The Lancet Oncology 11 (2010): 561-570.
3. Issels RD.  “Hyperthermia adds to chemotherapy”. European Journal of Cancer 44 (2008): 2546-2554.
4. Kaur P., et al. “Combined hyperthermia and radiotherapy for the treatment of cancer”. Cancers 3 (2011): 3799-3823.
5. Zhavrid Ed., et al. “Hyperthermia and hyperglicaemia in oncology”. Naukova Dimka, Kiev. (1987): 1- 256.
6. Yarmolenko SP., et al. “Thresholds for thermal damage to normal tissues: an update”. International Journal of Hyperthermia 27 (2011):  320-343.
7. Schlemmer M., et al. “Thermochemotherapy in pateints with extremity high-risk soft tissue sarcomas”. International Journal of Hyperthermia 26 (2010): 127-135.
8. Zhang HG., et al. “Hyperthermia on immune regulation: a temperature΄s story”. Cancer Letters 271 (2008): 191-204.
9. Vaupel P and Kelleher DK. “Pathophysiological and vascular characteristics of tumors and their importance for hyperthermia: heterogeneity is the key issue”. International Journal of Hyperthermia 26 (2010): 211-223. 
10. Sangeeta N Kale., et al. “Cerium doping and stoichiometry control for biomedical use of La0.7Sr0.3MnO3 nanoparticles: microwave absorption and cytotoxicity study”. Nanomedicine: Nanotechnology, Biology and Medicine 2 (2006): 217-2 21.
11. Jordan A., et al. “Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia”. International Journal of Hyperthermia 9 (1993): 51-68.
12. Thiesen B and Jordan A. “Clinical applications of magnetic nanoparticles for hyperthermia”. International Journal of Hyperthermia 24 (2008): 467-474.
13. Bellizzi G and Bucci O M. “On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia”. International Journal of Hyperthermia 26 (2010): 389-403.
14. Sonvico F., et al. “Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments”. Bioconjugate Chemistry 16 (2005): 1181 1188.
15. Tanaka K., et al. “Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma”.  Journal of Bioscience and Bioengineering 100 (2005): 112-115. 
16. Jordan A., et al. “The effect of thermo¬therapy using magnetic nanoparticles on rat malignant glioma”. Journal of Neuro-Oncology 78 (2006): 7-14. 
17. Zhao Q., et al. “Magnetic nanoparticle-based hyperthermia for head and neck cancer in mouse model”. Theranostics 2 (2012): 113-121.
18. Johannsen M., et al. “Magnetic nanoparticle hyperthermia for prostate cancer”. International Journal of Hyperthermia 26 (2010): 790-795.
19. Ito A., et al. “Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma”. Cancer Science 94 (2003): 308-313.
20. Bubnovskaya L., et al. “Nanohyperthermia of malignant tumors.II. In vivo tumor heating with manganese perovskite nanoparticles”. Experimental Oncology 34 (2012): 336-339.
21. Hilger I., et al. “Thermal ablation of tumors using magnetic nanoparticles: an In vivo feasibility study”. Investigative Radiology 37 (2002): 580-586. 
22. Jordan A., et al. “Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia”. Journal of Magnetism and Magnetic Materials 225 (2001): 118-126. 
23. Maier-Hauff K., et al. “Intracranial thermo¬therapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme”. Journal of Neuro-Oncology 81 (2007): 53-60.
24. Dey P and Nath TK. “Tunable room temperature low-field spin polarized tunneling magnetoresistance of La0.7Sr0.3MnO3 nanoparticles”.  Applied Physics Letters 89 (2006): 163102-3.
25. Bubnovskaya L., et al. “Magnetic fluid hyperthermia of rodent tumors using manganese perovskite nanoparticles”.  Journal of Nanoparticle Research (2014).
26. Laurent S., et al. “Magneticfluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles”. Advances in Colloid and Interface Science 166 (2011): 8-23.
27. Jordan A., et al. “Inductive heating of ferromagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia”. International Journal of Hyperthermia 9 (1997): 51-68.
28. Lévy M., et al. “Magnetically induced hyperthermia: size-dependent heating power of γ-Fe2O3 nanoparticles”. Journal of Physics: Condensed Matter 20 (2008): 204133.
29. Nikiforov VN., et al. “Magnetism and verwey transition in magnetite nanoparticles in thin polymer film”. Journal of Alloys and Compounds 569 (2013): 58-61. 
30. Vasseur S., et al. “Lanthanum manganese perovskite nanoparticles as possible in vivo mediators for magnetic hyperthermias”.  Journal of Magnetism and Magnetic Materials 302 (2006): 315-320. 
31. Pollert E., et al. “New Tc-tuned magnbetic nanoparticles for self-controlled hyperthermia”. Journal of Magnetism and Magnetic Materials 316 (2007): 122-125.
32. Solopan SO., et al. “Effect of nanoparticles agglomeration on electrical properties of La1−xAxMnO3 (A = Sr, Ba) nanopowder and ceramic solid solutions”. Solid State Sciences 14 (2012): 501-505.
33. Shlapa Y., et al. “Synthesis of ferromagnetic La1-xSrxMnO3 nanoparticles by precipitation from diethylene glycol solution and their properties”.  Journal of Advanced Ceramics 5 (2016): 197-203.
34. Shlapa Yu., et al. “Effect of synthesis method of La1 - xSrxMnO3 nanoparticles on their properties”. Nanoscale Research Letters 13 (2018): 1-7.
35. Dagotto E., et al. “Colossal magnetoresistant materials: the key role of phase separation”. Physics Reports 344.1 (2001): 153.
36. Uskoković V., et al. “Preparation of silica-coated lanthanum-strontium manganite particles with designable Curie point, for application in hyperthermia treatments”. International Journal of Applied Ceramic Technology 3 (2006): 134-143. 
37. Natividad E., et al. “New insights into the heating mechanisms and self-regulating abilities of manganite perovskite nanoparticles suitable for magnetic fluid hyperthermia”. Nanoscale 4 (2012): 3954-3962.
38. Shydlovska О., et al. “Synthesis, toxicity, genotoxicity, antioxidized and antiviral activities of (La,Sr)MnO3 and Fe3O4 nanoparticles”. European Journal of Nanomedicine 9 (2017): 33 - 43.
39. Handbook of Sol-gel Science and Technology: Processing, characterization and application, S. Sakka (Ed.), Kluwer Academic Publishers”. New York (2005): 1986. 
40. Belous AG., et al. “Effects of chemical composition and sintering temperature on the structure of La1-xSrxMnO3 solid solutions”. Inorganic Materials 39.2 (2003):161-170.
41. Peddis D., et al. “Interparticle interactions and magnetic anisotropy in cobalt ferrite nanoparticles: influence of molecular coating”. Chem Mater 24 (2012): 1062-1071. 
42. Ni J and Hollander D. “Application of the MTT-assay to functional studies of nouse intestinal intraepithelial lymphocytes”. Journal Clinical Lab Analmm 10 (1996): 42-52.
43. Luft JH. “Improvements in epoxy resin embedding methods”. The Journal of Biophysical and Biochemical Cytology 9 (1961): 409-414. 
44. Yelenich OV., et al. “Synthesis of iron oxide nanoparticles by different methods and study of their properties”. Solid State Phenomena 230 (2015): 108-113.
45. Lukyanova NY., et al. “Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin”. Experimental Oncology 31 (2009): 87-91.
46. Solopan S., et al. “Nanohyperthermia of malignant tumors. I. Lanthanum-strontium manganite magnetic fluid as potential inducer oftumor hyperthermia”. Experimental Oncology 33 (2011):131-135.
47. Larionov LF. “Chemotherapy of malignant tumor”. M (1962).
48. Zhao Q., et al. “Magnetic nanocomposite devices for cancer thermochemotherapy. In D.B.Reddy (ed.) Advances in nanocomposites: synthesis, characterization and industrial applications”. Academic Press (2010):  385-402.
49. Chekhun VF and Shishova YuV. “Modern view on the formation of drug resistance of tumor”. Oncologiya 2 (2000): 115.
50. Faute MA., et al. “Distinctive alteration of invasiveness, drug resistance and cell-cell organization in 3 D-cultires of MCF-7, a human breast cancer cell line, and its multidrug resistance variant”. Clinical and Experimental Metastasis 19 (2002): 161-166.
51. Lukianova NYu., et al. “Changes in the range of metalloproteins and their regulatory factors in growth dynamic of sensitive and resistant Guerin carcinoma”. Oncologiya 4 (2016): 247-254.
52. Hu C-M J and Zhang L. “Therapeutic nanoparticles to combat cancer drug resistance”. Current Drug Metabolism 10 (2009): 836-841.
53. Sulyok I., et al. “Effect of preoperative fever -range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery”. British Journal of Anaesthesia 109.5 (2012): 754-761.
54. Seifert G., et al. “Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspective”. Radiation Oncology 11 (2016): 65.
55. Kerbage Y., et al. “Laser intestinal thermotherapy application for breast surgery: current situation and new trends”. Breast 33 (2017): 145-152.
56. Baratti D., et al. “Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review”.  Critical Reviews in Oncology/Hematology 100 (2016): 209-222.

Citation

Citation: ML Bubnovskaya., et al. “Some Effects of Nanohyperthermia on the Basis of Lanthanum-Strontium Manganites (La, Sr) Mno3 Nanoparticles as Heating Mediators. Acta Scientific Cancer Biology 4.3 (2020): 08-15.

Copyright

Copyright: © 2020 ML Bubnovskaya., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.